All In Biotech

Free tool

FAERS Monitor: Gemtesa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213006 or its brand name (Gemtesa, Vibegron). Reports on generic versions are filed under their own applications.

Reports

8,828

Serious

2,702

31% of reports

Hospitalization

1,007

Death reported

462

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,194
  • diarrhoea440
  • headache419
  • urinary tract infection392
  • urinary retention335
  • death332
  • fatigue308
  • nausea288
  • drug effect less than expected285
  • inability to afford medication266
  • constipation263
  • dizziness243
  • fall242
  • urinary incontinence232
  • therapy interrupted223

Reports by year received

View as table
YearReports
20162
20173
20186
20198
202019
2021211
2022191
20231,842
20242,002
20252,278
20262,266

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,331 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
inability to afford medicationSignal26665.558.116,399
drug effect less than expectedSignal28546.741.612,465
urinary retentionSignal33524.221.77,350
urinary incontinenceSignal23218.816.53,866
therapy interruptedSignal2237.56.51,240
urinary tract infectionSignal3925.55.01,442
constipationSignal2632.92.6323
drug ineffectiveSignal1,1942.22.0791
fall2421.71.575
diarrhoea4401.61.5108
headache4191.61.595
dizziness2431.21.05
fatigue3080.90.81
death3320.90.82
nausea2880.90.86

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.